Farther Finance Advisors, LLC Catalyst Pharmaceuticals, Inc. Transaction History
Farther Finance Advisors, LLC
- $2.06 Trillion
- Q2 2024
A detailed history of Farther Finance Advisors, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 482 shares of CPRX stock, worth $9,746. This represents 0.0% of its overall portfolio holdings.
Number of Shares
482
Previous 412
16.99%
Holding current value
$9,746
Previous $6.49 Million
17.21%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CPRX
# of Institutions
285Shares Held
96.6MCall Options Held
29.2KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$378 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.13MShares$185 Million2.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$164 Million0.0% of portfolio
-
State Street Corp Boston, MA6.03MShares$122 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3MShares$60.7 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.08B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...